Viva Biotech Holdings
Research Viva Biotech Holdings (VB0) on Bullrun: market cap EUR 334.33M, P/E 16.2. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVB0
- ExchangeF
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 334.33M
- P/E16.2
- Financial periodFY2025
- RevenueCNY 1.73B
- Revenue growth-12.9%
- Net incomeCNY 219.76M
- Free cash flowCNY 109.68M
- Gross margin37.9%
Valuation Snapshot
latest market cap is EUR 334.33M; P/E is 16.2.
Peer valuation comparison
Latest P/E is 16.2x versus a Healthcare sector median of 24.46x (33.8% below).
Latest P/E is 16.2x versus a China median of 10.67x (51.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 1.73B | CNY 219.76M | CNY 109.68M | 37.9% | 0.09 | CNY 1.09B | CNY 1.33B | CNY 4.00B |
| FY2024 | CNY 1.99B | CNY 167.29M | CNY 182.32M | 34.6% | 0.06 | CNY 941.58M | CNY 1.28B | CNY 3.80B |
| FY2023 | CNY 2.16B | -CNY 116.11M | CNY 195.57M | 34.3% | -0.14 | CNY 1.04B | CNY 1.90B | CNY 3.69B |
| FY2022 | CNY 2.38B | -CNY 528.48M | CNY 136.51M | 34.3% | -0.28 | CNY 678.57M | CNY 2.82B | CNY 3.60B |
| FY2021 | CNY 2.10B | CNY 287.55M | -CNY 488.49M | 30.9% | 0.08 | CNY 800.95M | CNY 2.65B | CNY 3.91B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-15 | EUR 334.33M | 16.2 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
| Year | Dividends/share |
|---|---|
| FY2021 | 0 CNY |
About Viva Biotech Holdings
Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, including protein expression, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacology and DMPK;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Viva Biotech Holdings's market cap?
Viva Biotech Holdings's market capitalization is EUR 334.33M.
What is Viva Biotech Holdings's P/E ratio?
Viva Biotech Holdings's price-to-earnings (P/E) ratio is 16.2.
What does Viva Biotech Holdings do?
Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.